Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05066217 An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-G… |
Clemizole HCl | Épilepsie | Phase 3 | RECRUITING | En attente / non publié | Epygenix | United States, China, India, Italy, Poland, Romania, … | 2025-04-09 → 2029-11-01 | Ouvrir |
| NCT06132893 RISE 2 — A Study to Determine if BHV-7000 is Effective and Safe in Adul… |
BHV-7000 | Épilepsie | Phase 2/3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Biohaven Therapeutics Ltd. | United States, Argentina, Austria, Belgium, Chile, Cz… | 2024-03-14 → 2026-12 | Ouvrir |
| NCT02107989 Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and… |
MRI | Épilepsie | À vérifier | RECRUITING | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2014-03-11 → 2028-03-30 | Ouvrir |
| NCT04770220 APOLLOE4 — An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD … |
Experimental: ALZ-801 | Alzheimer | Phase 3 | COMPLETED | En attente / non publié | Alzheon Inc. | United States, Canada, Czechia, France, Germany, Icel… | 2021-05-19 → 2024-07-29 | Ouvrir |
| NCT05980949 Open-Label Extension Study to Assess the Long-Term Safety and Tolerabil… |
KarXT | Alzheimer | Phase 3 | RECRUITING | En attente / non publié | Karuna Therapeutics, Inc., a Bris… | United States, Argentina, Belgium, Brazil, Bulgaria, … | 2023-07-11 → 2027-09-07 | Ouvrir |
| NCT05834296 Study in Subjects With Mild-to-Moderate Alzheimer's Dementia |
ALZN002 (autologous DCs pulsed wi… | Alzheimer | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Alzamend Neuro, Inc. | United States · First Excellent Research Group, Doral… | 2023-07-05 → 2028-03-03 | Ouvrir |
| NCT05543681 CALMA — Clinical Trial on Agitation in Alzheimer's Dementia |
IGC-AD1-Active | Alzheimer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | IGC Pharma, LLC | United States, Canada, Puerto Rico · Baycrest Academy… | 2022-10-11 → 2026-11 | Ouvrir |
| NCT07667478 NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DIS… |
Repetitive Transcranial Magnetic … | Alzheimer | Non applicable | RECRUITING | En attente / non publié | Chi-Ying (Roy) Lin | United States · Baylor College of Medicine, Houston, … | 2026-04-15 → 2031-04-14 | Ouvrir |
| NCT07854327 LymphDAD — Restoring Cervical Lymphatic Drainage in Alzheimer's Disease |
Cervical lymphovenous anastomosis… | Alzheimer | Non applicable | RECRUITING | En attente / non publié | University of Siena | Italy · Azienda Ospedaliera Universitaria Le Scotte, … | 2026-07-01 → 2028-12-31 | Ouvrir |
| NCT05326750 Non-invasive Neurostimulation as a Tool for Diagnostics and Management … |
Gamma tACS (40 Hz) over the super… | Alzheimer | Non applicable | RECRUITING | En attente / non publié | Kuopio University Hospital | Finland · Kuopio University Hospital, Kuopio, Finland | 2022-11-21 → 2032-07 | Ouvrir |
| NCT06887192 A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatme… |
ML-007C-MA | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | MapLight Therapeutics | United States, Argentina, Bulgaria, Canada, Chile, Cz… | 2025-08-15 → 2027-12 | Ouvrir |
| NCT07142278 DU-PRISM — DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid… |
DUVAX 200 µg | Alzheimer | Phase 1 | RECRUITING | En attente / non publié | Nuravax, Inc. | United States · Palm Springs Community Health Center,… | 2026-09-25 → 2027-07-31 | Ouvrir |
| NCT07579884 To Evaluate the Safety and Efficacy of RP902 Tablets |
RP902 | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | Risen (Suzhou) Pharma Tech Co., L… | China · Beijing Tiantan Hospital, Capital Medical Uni… | 2026-07-14 → 2031-05 | Ouvrir |
| NCT07721467 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilo… |
Psilocybin | Alzheimer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | National Institute on Aging (NIA) | United States · National Institute of Aging, Clinical… | 2026-10-07 → 2030-12-31 | Ouvrir |
| NCT07756294 REVITAA-ALZ — Restoring Vascular and Insulin Function To Augment Anti-A… |
Empagliflozin | Alzheimer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Wake Forest University Health Sci… | United States · Wake Forest Alzheimer's Disease Resea… | 2026-11 → 2028-04 | Ouvrir |
| NCT07169630 PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer … |
18F-PF974 | Alzheimer | Phase 1 | RECRUITING | En attente / non publié | National Institute of Mental Heal… | United States · National Institutes of Health Clinica… | 2026-10-07 → 2030-04-11 | Ouvrir |
| NCT06189963 Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disea… |
SNK01 | Alzheimer | Phase 1/2 | RECRUITING | En attente / non publié | NKGen Biotech, Inc. | United States, Canada · AdventHealth Research Institu… | 2023-11-21 → 2028-06 | Ouvrir |
| NCT04261569 Clinical Trial for Near Infrared Endoventricular Illumination for Neuro… |
Ev-NIRT | Parkinson | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | University Hospital, Grenoble | France · CLINATEC, Grenoble, France | 2020-12-14 → 2032-04 | Ouvrir |
| NCT01010802 Safety Study of Erythropoietin (EPO) in Parkinson's Disease |
Erythropoietin human recombinant … | Parkinson | Phase 1 | COMPLETED | En attente / non publié | International Center for Neurolog… | Cuba · Clinic of Movement Disorders, International Ce… | 2008-08 → 2009-05 | Ouvrir |
| NCT07080775 The Safety,Tolerability, Efficacy of XS411 Cell Injection for the Treat… |
human allogeneic induced pluripot… | Parkinson | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | XellSmart Therapeutics (Shanghai)… | China · Beijing Tiantan Hospital, Beijing, China | 2025-08-05 → 2028-07 | Ouvrir |
| NCT06285643 A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGEN… |
AAV2-GDNF gene therapy | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | AskBio Inc | United States, Germany, Poland, United Kingdom · CenE… | 2024-06-11 → 2028-08-31 | Ouvrir |
| NCT06565195 PROSPECT-PD — A Clinical Trial of LY3962681 in Healthy Volunteers and i… |
LY3962681 | Parkinson | Phase 1 | RECRUITING | En attente / non publié | Prevail Therapeutics | United States, Germany, Japan, Netherlands, United Ki… | 2024-08-27 → 2030-07-23 | Ouvrir |
| NCT04957095 Motor Network Physiology |
Apomorphine Injectable Solution | Parkinson | Non applicable | RECRUITING | En attente / non publié | University of Texas Southwestern … | United States · UT Southwestern Medical Center, Dalla… | 2022-02-18 → 2028-12-01 | Ouvrir |
| NCT06015841 VacSYn — A Study to Evaluate the Effects of ACI-7104.056 in Patients Wi… |
ACI-7104.056 at Dose A | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | AC Immune SA | Germany, Spain, United Kingdom · Hospital de la Santa… | 2023-07-24 → 2028-06 | Ouvrir |
| NCT06582212 Lady-PD — Enabling Women With Parkinson's Disease to Identify and Bette… |
Mymovesmatter mobile application | Parkinson | Non applicable | RECRUITING | En attente / non publié | University Hospital, Grenoble | France · CHU Grenoble Alpes, Grenoble, France | CHU N… | 2025-03-12 → 2027-09-12 | Ouvrir |